PATENT CLAIM ANALYSIS

Application Number: 16129311
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "002100"]

Abstract:
This invention relates to improved uses of botulinum neurotoxins in the treatment of sialorrhea or diseases or conditions relating to increased saliva production. In particular are botulinum neurotoxins disclosed which are administered into parotid and submandibular glands in a dose ratio between 1.45 to 1 and 1.7 to 1.

Claim (Index 5):
The method according to  claim 1 , wherein said botulinum neurotoxin is injected into one site of each submandibular gland and/or into one site of each parotid gland.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 97.0
- Lexical Diversity: 1.30769
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11795210', '14945804', '14166434', '15735417', '11156502']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7726973427896618
- 35 USC 102 Novelty (BERT): 0.4969295445124896
- Combined Prediction Score: 0.7451205629619446
- Mean Citation Score: 247.511704
- Max Citation Score: 259.13467
- Similarity Product: 210.2373580594552

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test